European Medicines Agency - Regulatory - Regulation of medicines

4 - Quality management



    Description

Name

 

EPLTN - European Paediatric Liver Transplantation Network

Documented adherence to GCP guideline Yes The current network trial has been designed to comply with EU directive 2001/20/EC on clinical trials.
Documented adherence to the ethical considerations for clinical trials in children Yes The current project has been passed by local ethical bodies to comply with the special ethical requirements for paediatric trials in X participating sites. Final agreement of the local ethical body is still pending in Y centres. Documentation on the ethical approval of all local and/or national ethical bodies involved can be obtained via U.Baumann.
Documented adherence to ethical considerations Yes The current project has been passed by local ethical bodies to comply with the special ethical requirements for paediatric trials in all participating sites.
Availability of Standard Operating Procedures (SOP) Yes Specific SOPs have been developed in agreement with good clinical practice standards for the current network trial. Available SOPs are attached.
Capacity to monitor studies
(academic trials industry sponsored trials)
Yes Monitoring according to ICH 6 Cood Clinical Practice Guideline has been implemented by the individual sites.
Capacity to monitor performance of collaborating centres Yes Trial monitoring will be provided by a clinical trials unit at the initiating site for the current network study. In the remaining sites, monitoring will be performed either by a local clinical trials unit or an external CRO as locally applicable.
Quality control and quality assurance, raceability and data safety Yes see comment to 4.6